Hemofiltration in sepsis and systemic inflammatory response syndrome: The role of dosing and timing

Journal of Critical Care

Volumn 22, Issue 1, 2007, Pages 1-12

  Bouman, Catherine S C ^a   Oudemans van Straaten, Heleen M ^a   Schultz, Marcus J ^a,b   Vroom, Margreeth B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

Cytokine; Hemofiltration; Mediator; Sepsis; SIRS

Indexed keywords

ARTICLE; CELL HETEROGENEITY; CLINICAL FEATURE; CRITICAL ILLNESS; DATA BASE; EMBASE; GAS EXCHANGE; HEMODYNAMICS; HEMOFILTRATION; HISTOPATHOLOGY; HUMAN; MEDICAL RESEARCH; MEDLINE; MULTIPLE ORGAN FAILURE; NONHUMAN; SEPSIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULTRAFILTRATION;

ANIMALS; CLINICAL TRIALS; CRITICAL ILLNESS; HEMOFILTRATION; HUMANS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33947268692     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2006.05.002     Document Type: Article

References (75)

1. Bellomo R., and Ronco C. Continuous renal replacement therapy: continuous blood purification in the intensive care unit. Ann Acad Med Singapore 27 (1998) 426-429
2. Gotloib L., Barzilay E., Shustak A., et al. Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsis: preliminary report. Crit Care Med 12 (1984) 997-1000
3. De Vriese A.S., Colardyn F.A., Philippe J.J., et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10 (1999) 846-853
4. Bone R.C. Important new findings in sepsis. JAMA 278 (1997) 249
5. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138-150
6. Ronco C., Ricci Z., and Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Curr Opin Nephrol Hypertens 10 (2001) 755-761
7. Reiter K., Bellomo R., Ronco C., et al. Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock?. Crit Care 6 (2002) 18-21
8. Bellomo R., Honore P.M., Matson J., et al. Extracorporeal blood treatment (EBT) methods in SIRS/sepsis. Int J Artif Organs 28 (2005) 450-458
9. De Vriese A.S., Vanholder R.C., Pascual M., et al. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?. Intensive Care Med 25 (1999) 903-910
10. Venkataraman R., Kellum J.A., and Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 17 (2002) 246-250
11. Grootendorst A.F., van Bommel E.F., van der Hoven B., et al. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18 (1992) 235-240
12. Lee P.A., Weger G.W., Pryor R.W., et al. Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 26 (1998) 730-737
13. Rogiers P., Zhang H., Pauwels D., et al. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med 31 (2003) 1219-1225
14. Yekebas E.F., Strate T., Zolmajd S., et al. Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 62 (2002) 1806-1818
15. Brunet S., Leblanc M., Geadah D., et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 34 (1999) 486-492
16. Kellum J.A., Johnson J.P., Kramer D., et al. Diffusive versus convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26 (1998) 1995-2000
17. Bouman C.S., van Olden R.W., and Stoutenbeek C.P. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 16 (1998) 261-268
18. Clark W.R., Hamburger R.J., and Lysaght M.J. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int 56 (1999) 2005-2015
19. Clark W.R., and Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 13 Suppl 1 (2002) S41-S47
20. Morgera S. Management of acute renal failure with high permeability haemofiltration in sepsis: practical aspects. Int J Intensive Care (2006) 139-145
21. Mariano F., Tetta C., Guida G., et al. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int 60 (2001) 1598-1605
22. Morgera S., Haase M., Rocktaschel J., et al. High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 18 (2003) 2570-2576
23. Morgera S., Klonower D., Rocktaschel J., et al. TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients?. Nephrol Dial Transplant 18 (2003) 1361-1369
24. Morgera S., Slowinski T., Melzer C., et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43 (2004) 444-453
25. Uchino S., Bellomo R., Morimatsu H., et al. Cytokine dialysis: an ex vivo study. ASAIO J 48 (2002) 650-653
26. Kellum J.A., and Dishart M.K. Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care 6 (2002) 429-433
27. van Bommel E.F., Hesse C.J., Jutte N.H., et al. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Ren Fail 19 (1997) 443-454
28. Schulman G. A review of the concept of biocompatibility. Kidney Int Suppl 41 (1993) S209-S212
29. Gomez A., Wang R., Unruh H., et al. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73 (1990) 671-685
30. Mink S.N., Jha P., Wang R., et al. Effect of continuous arteriovenous hemofiltration combined with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 83 (1995) 178-190
31. DiScipio A.W., and Burchard K.W. Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis. Am J Surg 173 (1997) 174-180
32. Stein B., Pfenninger E., Grunert A., et al. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 16 (1990) 494-499
33. Stein B., Pfenninger E., Grunert A., et al. The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med 17 (1991) 293-298
34. Cole L., Bellomo R., Hart G., et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30 (2002) 100-106
35. John S., Griesbach D., Baumgartel M., et al. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 16 (2001) 320-327
36. Phu N.H., Hien T.T., Mai N.T., et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 347 (2002) 895-902
37. Sander A., Armbruster W., Sander B., et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23 (1997) 878-884
38. Heering P., Morgera S., Schmitz F.J., et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23 (1997) 288-296
39. Hoffmann J.N., Hartl W.H., Deppisch R., et al. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22 (1996) 1360-1367
40. Klouche K., Cavadore P., Portales P., et al. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 15 (2002) 150-157
41. Kruger I., Jacobi C., and Landwehr P. Effects of continuous venovenous hemofiltration on pulmonary function and hemodynamics in postoperative septic multiorgan failure. Contrib Nephrol 116 (1995) 108-111
42. Level C., Chauveau P., Guisset O., et al. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 7 (2003) R160-R166
43. Meloni C., Morosetti M., Turani F., et al. Cardiac function and oxygen balance in septic patients during continuous hemofiltration. Blood Purif 16 (1998) 140-146
44. Ossenkoppele G.J., van der M.J., Bronsveld W., and Thijs L.G. Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 13 (1985) 102-104
45. Blinzler L., Hausser J., Bodeker H., et al. Conservative treatment of severe necrotizing pancreatitis using early continuous venovenous hemofiltration. Contrib Nephrol 93 (1991) 234-236
46. Cosentino F., Paganini F., Lockrem J., et al. Continuous arteriovenous hemofiltration in the adult respiratory distress syndrome. Contrib Nephrol 93 (1991) 94-97
47. Gotloib L., Barzilay E., Shustak A., et al. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 13 (1986) 123-132
48. Matamis D., Tsagourias M., Koletsos K., et al. Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients. Intensive Care Med 20 (1994) 431-436
49. Heidemann S.M., Ofenstein J.P., and Sarnaik A.P. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 44 (1994) 183-187
50. Murphey E.D., Fessler J.F., Bottoms G.D., et al. Effects of continuous venovenous hemofiltration on cardiopulmonary function in a porcine model of endotoxin-induced shock. Am J Vet Res 58 (1997) 408-413
51. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
52. Lee P.A., Matson J.R., Pryor R.W., et al. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21 (1993) 914-924
53. Ullrich R., Roeder G., Lorber C., et al. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology 95 (2001) 428-436
54. Bellomo R., Kellum J.A., Gandhi C.R., et al. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161 (2000) 1429-1436
55. Rogiers P., Zhang H., Smail N., et al. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27 (1999) 1848-1855
56. Grootendorst A.F., van Bommel E.F., van Leengoed L.A., et al. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8 (1993) 161-169
57. Grootendorst A.F., van Bommel E.F., van Leengoed L.A., et al. High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2 (1994) 72-78
58. Wang H., Zhang Z.H., Yan X.W., et al. Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol 11 (2005) 127-131
59. Yekebas E.F., Eisenberger C.F., Ohnesorge H., et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29 (2001) 1423-1430
60. Freeman B.D., Yatsiv I., Natanson C., et al. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 180 (1995) 286-292
61. Cole L., Bellomo R., Journois D., et al. High-volume haemofiltration in human septic shock. Intensive Care Med 27 (2001) 978-986
62. Jiang H.L., Xue W.J., Li D.Q., et al. Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 11 (2005) 4815-4821
63. Laurent I., Adrie C., Vinsonneau C., et al. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 46 (2005) 432-437
64. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106 (2002) 562-568
65. Honore P.M., Jamez J., Wauthier M., et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28 (2000) 3581-3587
66. Joannes-Boyau O., Rapaport S., Bazin R., et al. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50 (2004) 102-109
67. Oudemans-van Straaten H.M., Bosman R.J., van der Spoel J.I., et al. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25 (1999) 814-821
68. Ratanarat R., Brendolan A., Piccinni P., et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9 (2005) R294-R302
69. Wang H., Li W.Q., Zhou W., et al. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 9 (2003) 2096-2099
70. Honore P.M., and Matson J.R. Short-term high-volume hemofiltration in sepsis: perhaps the right way is to start with. Crit Care Med 30 (2002) 1673-1674
71. Mink S.N., Li X., Bose D., et al. Early but not delayed continuous arteriovenous hemofiltration improves cardiovascular function in sepsis in dogs. Intensive Care Med 25 (1999) 733-743
72. Yekebas E.F., Treede H., Knoefel W.T., et al. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 229 (1999) 514-522
73. Veenman J.N., Dujardint C.L., Hoek A., et al. High volume continuous venovenous haemofiltration (HV-CVVH) in an equine endotoxaemic shock model. Equine Vet J 34 (2002) 516-522
74. Morgera S., Rocktaschel J., Haase M., et al. Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med 29 (2003) 1989-1995
75. Uchino S., Bellomo R., Goldsmith D., et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 28 (2002) 651-655